Centre Hospitalier Francois Mitterand

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context	ALK+ Non-Small-Cell Lung Carcinoma	Recruiting	Not applicable	2026-05-06		NCT06487078

Clinical trials